KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Inventory Average (2016 - 2025)

West Pharmaceutical Services' Inventory Average history spans 16 years, with the latest figure at $441.0 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 13.33% year-over-year to $441.0 million; the TTM value through Dec 2025 reached $441.0 million, up 13.33%, while the annual FY2025 figure was $410.4 million, 1.13% up from the prior year.
  • Inventory Average for Q4 2025 was $441.0 million at West Pharmaceutical Services, up from $429.6 million in the prior quarter.
  • Across five years, Inventory Average topped out at $448.2 million in Q2 2023 and bottomed at $315.8 million in Q1 2021.
  • The 5-year median for Inventory Average is $413.2 million (2022), against an average of $403.2 million.
  • The largest annual shift saw Inventory Average grew 29.75% in 2021 before it decreased 11.44% in 2025.
  • A 5-year view of Inventory Average shows it stood at $366.1 million in 2021, then rose by 13.07% to $414.0 million in 2022, then increased by 4.66% to $433.2 million in 2023, then dropped by 10.19% to $389.1 million in 2024, then rose by 13.33% to $441.0 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Inventory Average are $441.0 million (Q4 2025), $429.6 million (Q3 2025), and $404.9 million (Q2 2025).